Studies on soft tissue sarcomas and bone tumors in Germany

被引：0
|
作者：
Lindner, Lars H. [1 ]
Kasper, Bernd [2 ]
机构：
[1] LMU Klinikum, Sarkomzentrum SarKUM, Marchioninistr 15, D-81377 Munich, Germany
[2] Univ Med Mannheim, Mannheim Canc Ctr MCC, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
来源：
ONKOLOGE | 2022年 / 28卷 / SUPPL 1期
关键词：
PHASE-II TRIAL; DOXORUBICIN;
D O I：
10.1007/s00761-022-01110-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：64 / 66
页数：3
相关论文
共 50 条
  • [41] Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
    Liffers, Sven-T
    Tilkorn, Daniel J.
    Stricker, Ingo
    Junge, Christoph Guenter
    Al-Benna, Sammy
    Vogt, Markus
    Verdoodt, Berlinda
    Steinau, Hans-U
    Tannapfel, Andrea
    Tischoff, Iris
    Mirmohammadsadegh, Alireza
    BMC CANCER, 2013, 13
  • [42] Soft tissue sarcomas: Questions about reported clinical benefit
    Penel, Nicolas
    Cousin, Sophie
    Kotecki, Nuria
    BULLETIN DU CANCER, 2015, 102 (10) : 804 - 805
  • [43] Primary adult soft tissue sarcomas: analysis of 294 patients
    Alkis, Necati
    Muallaoglu, Sadik
    Kocer, Murat
    Arslan, Ulku Yalcintas
    Durnali, Ayse Gok
    Tokluoglu, Saadet
    Celenkoglu, Gokhan
    Paksoy, Fatma
    Coskun, Ugur
    MEDICAL ONCOLOGY, 2011, 28 (01) : 391 - 396
  • [44] The challenge of finding new therapeutic avenues in soft tissue sarcomas
    Kasper, Bernd
    CLINICAL SARCOMA RESEARCH, 2019, 9
  • [45] Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
    Sven-T Liffers
    Daniel J Tilkorn
    Ingo Stricker
    Christoph Günter Junge
    Sammy Al-Benna
    Markus Vogt
    Berlinda Verdoodt
    Hans-U Steinau
    Andrea Tannapfel
    Iris Tischoff
    Alireza Mirmohammadsadegh
    BMC Cancer, 13
  • [46] High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
    Nielsen, OS
    Dombernowsky, P
    Mouridsen, H
    Crowther, D
    Verweij, J
    Buesa, J
    Steward, W
    Daugaard, S
    van Glabbeke, M
    Kirkpatrick, A
    Tursz, T
    BRITISH JOURNAL OF CANCER, 1998, 78 (12) : 1634 - 1639
  • [47] Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas
    Kantidakis, Georgios
    Litiere, Saskia
    Neven, Anouk
    Vinches, Marie
    Judson, Ian
    Schoeffski, Patrick
    Wardelmann, Eva
    Stacchiotti, Silvia
    D'Ambrosio, Lorenzo
    Marreaud, Sandrine
    van der Graaf, Winette T. A.
    Kasper, Bernd
    Fiocco, Marta
    Gelderblom, Hans
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 253 - 268
  • [48] Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
    Schulte, Brian
    Mohindra, Nisha
    Milhem, Mohammed
    Attia, Steven
    Robinson, Steven
    Monga, Varun
    Hirbe, Angela C.
    Oppelt, Peter
    Charlson, John
    Helenowski, Irene
    Abbinanti, Susan
    Cehic, Rasima
    Okuno, Scott
    Van Tine, Brian A.
    Agulnik, Mark
    BRITISH JOURNAL OF CANCER, 2021, 125 (04) : 528 - 533
  • [49] Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives
    Badalamenti, Giuseppe
    Messina, Carlo
    De Luca, Ida
    Musso, Emmanuela
    Casarin, Alessandra
    Incorvaia, Lorena
    RADIOLOGIA MEDICA, 2019, 124 (04): : 259 - 265
  • [50] Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy
    Liu, Han
    Zhang, Hao
    Han, Yafei
    Hu, Yan
    Geng, Zhen
    Su, Jiacan
    THERANOSTICS, 2022, 12 (15): : 6576 - 6594
12345